Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SK

Sunil Kumar KC — 27 Patents

SASamumed: 27 patents #5 of 19Top 30%
San Diego, CA: #1,481 of 23,606 inventorsTop 7%
California: #19,967 of 386,348 inventorsTop 6%
Overall (All Time): #142,059 of 4,157,543Top 4%
27 Patents All Time
Sunil Kumar KC has been granted 27 US patents while listed as an inventor at Samumed. The first was granted in 2013 and the most recent in June 2020. Sunil Kumar KC ranks #142,059 of 4,157,543 US inventors in our database (top 3.4%). Patent records list Sunil Kumar KC in San Diego, CA, US.

Issued Patents All Time

Showing 1–25 of 27 patents

Patent #TitleCo-InventorsDate
10669240 5-substituted indazole-3-carboxamides and preparation and use thereof John Hood, David Mark Wallace, Gopi Kumar Mittapalli, Brian Joseph Hofilena, Chi Ching Mak +2 more 2020-06-02
9908867 3-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof John Hood 2018-03-06
9828372 2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof David Mark Wallace, Jianguo Cao, Chandramouli Chiruta, John Hood 2017-11-28
9802916 Indazole-3-carboxamides and their use as Wnt/beta-catenin signaling pathway inhibitors John Hood 2017-10-31
9745271 5-substituted indazole-3-carboxamides and preparation and use thereof John Hood, David Mark Wallace, Gopi Kumar Mittapalli, Brian Joseph Hofilena, Chi Ching Mak +2 more 2017-08-29
9586977 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof John Hood, David Mark Wallace 2017-03-07
9533976 γ-diketones as WNT/β-catenin signaling pathway activators David Mark Wallace, John Hood, Charlene F. Barroga 2017-01-03
9493437 β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activators David Mark Wallace, John Hood, Charlene F. Barroga 2016-11-15
9381192 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof John Hood, David Mark Wallace 2016-07-05
9303010 β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators David Mark Wallace, John Hood, Charlene F. Barroga 2016-04-05
9233104 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof John Hood, David Mark Wallace 2016-01-12
9199991 Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof John Hood, David Mark Wallace 2015-12-01
9090613 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof John Hood, David Mark Wallace 2015-07-28
9067939 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof John Hood, David Mark Wallace 2015-06-30
9012472 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof John Hood, David Mark Wallace 2015-04-21
8987298 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof John Hood, David Mark Wallace 2015-03-24
8921413 β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activators David Mark Wallace, John Hood, Charlene F. Barroga 2014-12-30
8901150 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof John Hood, David Mark Wallace 2014-12-02
8883822 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof John Hood, David Mark Wallace 2014-11-11
8846714 1H-pyrazolo[3,4-β]pyridines and therapeutic uses thereof John Hood, David Mark Wallace 2014-09-30
8703794 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof John Hood, David Mark Wallace 2014-04-22
8697887 Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors John Hood 2014-04-15
8673936 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof John Hood, David Mark Wallace 2014-03-18
8664241 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof John Hood, David Mark Wallace 2014-03-04
8629176 β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activators David Mark Wallace, John Hood, Charlene F. Barroga 2014-01-14